These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33189994)

  • 1. Prodrugs for nitroreductase based cancer therapy-4: Towards prostate cancer targeting: Synthesis of N-heterocyclic nitro prodrugs, Ssap-NtrB enzymatic activation and anticancer evaluation.
    Güngör T; Tokay E; Güven Gülhan Ü; Hacıoğlu N; Çelik A; Köçkar F; Ay M
    Bioorg Chem; 2020 Dec; 105():104450. PubMed ID: 33189994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prodrugs for nitroreductase-based cancer therapy-3: Antitumor activity of the novel dinitroaniline prodrugs/Ssap-NtrB enzyme suicide gene system: Synthesis, in vitro and in silico evaluation in prostate cancer.
    Tokay E; Güngör T; Hacıoğlu N; Önder FC; Gülhan ÜG; Tok TT; Çelik A; Ay M; Köçkar F
    Eur J Med Chem; 2020 Feb; 187():111937. PubMed ID: 31841727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prodrugs for Nitroreductase Based Cancer Therapy- 1: Metabolite Profile, Cell Cytotoxicity and Molecular Modeling Interactions of Nitro Benzamides with Ssap-NtrB.
    Gungor T; Yetis G; Onder FC; Tokay E; Tok TT; Celik A; Ay M; Kockar F
    Med Chem; 2018; 14(5):495-507. PubMed ID: 29189173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRODRUGS FOR NITROREDUCTASE BASED CANCER THERAPY- 2: Novel amide/Ntr combinations targeting PC3 cancer cells.
    Güngör T; Önder FC; Tokay E; Gülhan ÜG; Hacıoğlu N; Tok TT; Çelik A; Köçkar F; Ay M
    Eur J Med Chem; 2019 Jun; 171():383-400. PubMed ID: 30928710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the abilities of diverse nitroaromatic prodrug metabolites to exit a model Gram negative vector for bacterial-directed enzyme-prodrug therapy.
    Chan-Hyams JVE; Copp JN; Smaill JB; Patterson AV; Ackerley DF
    Biochem Pharmacol; 2018 Dec; 158():192-200. PubMed ID: 30352235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the nitroreductase prodrug-activating system. Crystal structures of complexes with the inhibitor dicoumarol and dinitrobenzamide prodrugs and of the enzyme active form.
    Johansson E; Parkinson GN; Denny WA; Neidle S
    J Med Chem; 2003 Sep; 46(19):4009-20. PubMed ID: 12954054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrobenzyl carbamate prodrugs of enediynes for nitroreductase gene-directed enzyme prodrug therapy (GDEPT).
    Hay MP; Wilson WR; Denny WA
    Bioorg Med Chem Lett; 1999 Dec; 9(24):3417-22. PubMed ID: 10617083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of alternative prodrugs for use with E. coli nitroreductase in 'suicide gene' approaches to cancer therapy.
    Bailey SM; Knox RJ; Hobbs SM; Jenkins TC; Mauger AB; Melton RG; Burke PJ; Connors TA; Hart IR
    Gene Ther; 1996 Dec; 3(12):1143-50. PubMed ID: 8986441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological evaluation of cyclic and acyclic nitrobenzylphosphoramide mustards for E. coli nitroreductase activation.
    Jiang Y; Han J; Yu C; Vass SO; Searle PF; Browne P; Knox RJ; Hu L
    J Med Chem; 2006 Jul; 49(14):4333-43. PubMed ID: 16821793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creation and screening of a multi-family bacterial oxidoreductase library to discover novel nitroreductases that efficiently activate the bioreductive prodrugs CB1954 and PR-104A.
    Prosser GA; Copp JN; Mowday AM; Guise CP; Syddall SP; Williams EM; Horvat CN; Swe PM; Ashoorzadeh A; Denny WA; Smaill JB; Patterson AV; Ackerley DF
    Biochem Pharmacol; 2013 Apr; 85(8):1091-103. PubMed ID: 23399641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of a microfluidic reactor for screening cancer prodrug activation using silica-immobilized nitrobenzene nitroreductase.
    Berne C; Betancor L; Luckarift HR; Spain JC
    Biomacromolecules; 2006 Sep; 7(9):2631-6. PubMed ID: 16961327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactivation of dinitrobenzamide mustards by an E. coli B nitroreductase.
    Anlezark GM; Melton RG; Sherwood RF; Wilson WR; Denny WA; Palmer BD; Knox RJ; Friedlos F; Williams A
    Biochem Pharmacol; 1995 Aug; 50(5):609-18. PubMed ID: 7669063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colletotrichalactones A-Ca, unusual 5/6/10-fused tricyclic polyketides produced by an endophytic fungus, Colletotrichum sp. JS-0361.
    Bang S; Kwon HE; Baek JY; Jang DS; Kim S; Nam SJ; Lee D; Kang KS; Shim SH
    Bioorg Chem; 2020 Dec; 105():104449. PubMed ID: 33189995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of NfsA-like nitroreductases from Neisseria meningitidis and Bartonella henselae for enzyme-prodrug therapy, targeted cellular ablation, and dinitrotoluene bioremediation.
    Rich MH; Sharrock AV; Hall KR; Ackerley DF; MacKichan JK
    Biotechnol Lett; 2018 Feb; 40(2):359-367. PubMed ID: 29147875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel nitroreductases from Bacillus cereus and their interaction with the CB1954 prodrug.
    Gwenin VV; Poornima P; Halliwell J; Ball P; Robinson G; Gwenin CD
    Biochem Pharmacol; 2015 Dec; 98(3):392-402. PubMed ID: 26415543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E. coli nitroreductase/CB1954 gene-directed enzyme prodrug therapy: role of arylamine N-acetlytransferase 2.
    Mitchell DJ; Minchin RF
    Cancer Gene Ther; 2008 Nov; 15(11):758-64. PubMed ID: 18600257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time dependent HPLC analysis of the product ratio of enzymatically reduced prodrug CB1954 by a modified and immobilised nitroreductase.
    Ball P; Thompson E; Anderson S; Gwenin V; Gwenin C
    Eur J Pharm Sci; 2019 Jan; 127():217-224. PubMed ID: 30414836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitroreductase-based GDEPT.
    Denny WA
    Curr Pharm Des; 2002; 8(15):1349-61. PubMed ID: 12052212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer activities of emetine prodrugs that are proteolytically activated by the prostate specific antigen (PSA) and evaluation of in vivo toxicity of emetine derivatives.
    Akinboye ES; Rosen MD; Bakare O; Denmeade SR
    Bioorg Med Chem; 2017 Dec; 25(24):6707-6717. PubMed ID: 29153549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization of colorectal and pancreatic cancer cell lines to the prodrug 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954) by retroviral transduction and expression of the E. coli nitroreductase gene.
    Green NK; Youngs DJ; Neoptolemos JP; Friedlos F; Knox RJ; Springer CJ; Anlezark GM; Michael NP; Melton RG; Ford MJ; Young LS; Kerr DJ; Searle PF
    Cancer Gene Ther; 1997; 4(4):229-38. PubMed ID: 9253508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.